20030411
 Business Brief -- Solvay SA: Hormone-Replacement Drug Faces Assessment by FDA   The Wall Street Journal,  Apr 11, 2003  The Food and Drug Administration said it is reassessing its view of a popular hormone-replacement therapy, targeting a drug that has remained on the market for decades without agency approval.   
